Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia (NCT01886872)
A Randomized Phase III Study of Bendamustine Plus Rituximab Versus Ibrutinib Plus Rituximab Versus Ibrutinib Alone in Untreated Older Patients (โฅ 65 Years of Age) With Chronic Lymphocytic Leukemia (CLL)
๐ฉบ Plain-English Summary (8th-Grade Level)
This randomized phase III trial studies rituximab with bendamustine hydrochloride or ibrutinib to see how well they work compared to ibrutinib alone in treating older patients with previously untreated chronic lymphocytic leukemia. Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. A monoclonal antibody is a type of protein that can bind to certain targets in the body, such as molecules that cause the body to make an immune response (antigens). Chemotherapy drugs, such as bendamustine hydrochloride, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. It is not yet known whether rituximab with bendamustine hydrochloride may work better than rituximab and ibrutinib or ibrutinib alone in treating chronic lymphocytic leukemia.
Who can join: Review the eligibility criteria below.
Location: University of Alabama at Birmingham Cancer Center โ Birmingham, Alabama
Age range: 65 Years
๐งช Interventions in This Study
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (937 Sites)
Showing the first 25 of 937 sites.
- University of Alabama at Birmingham Cancer Center โ Birmingham, Alabama
- Anchorage Radiation Therapy Center โ Anchorage, Alaska
- Alaska Breast Care and Surgery LLC โ Anchorage, Alaska
- Alaska Oncology and Hematology LLC โ Anchorage, Alaska
- Alaska Regional Hospital โ Anchorage, Alaska
- Alaska Women's Cancer Care โ Anchorage, Alaska
- Anchorage Oncology Centre โ Anchorage, Alaska
- Katmai Oncology Group โ Anchorage, Alaska
- Providence Alaska Medical Center โ Anchorage, Alaska
- Mayo Clinic Hospital in Arizona โ Phoenix, Arizona
- Mayo Clinic in Arizona โ Scottsdale, Arizona
- Banner University Medical Center - Tucson โ Tucson, Arizona
- University of Arizona Cancer Center-North Campus โ Tucson, Arizona
- Onvida Health Yuma Medical Center โ Yuma, Arizona
- CHI Saint Vincent Cancer Center Hot Springs โ Hot Springs, Arkansas
- NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro โ Jonesboro, Arkansas
- Kaiser Permanente-Anaheim โ Anaheim, California
- Kaiser Permanente-Deer Valley Medical Center โ Antioch, California
- PCR Oncology โ Arroyo Grande, California
- Sutter Auburn Faith Hospital โ Auburn, California
- Sutter Cancer Centers Radiation Oncology Services-Auburn โ Auburn, California
- Kaiser Permanente-Baldwin Park โ Baldwin Park, California
- Kaiser Permanente-Bellflower โ Bellflower, California
- Alta Bates Summit Medical Center-Herrick Campus โ Berkeley, California
- Providence Saint Joseph Medical Center/Disney Family Cancer Center โ Burbank, California
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Stage I Chronic Lymphocytic Leukemia
- Alemtuzumab-Ofatumumab in Previously Untreated Symptomatic Chronic Lymphocytic Leukemia โ Chicago, Illinois
Explore by condition: All Stage I Chronic Lymphocytic Leukemia clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.